Leisure Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$266K Hold
9,483
0.09% 126
2025
Q4
$236K Hold
9,483
0.08% 130
2025
Q3
$242K Sell
9,483
-2,167
-19% -$53.5K 0.08% 124
2025
Q2
$282K Buy
11,650
+1,211
+12% +$28.2K 0.11% 116
2025
Q1
$265K Hold
10,439
0.11% 122
2024
Q4
$277K Sell
10,439
-670
-6% -$18.2K 0.11% 123
2024
Q3
$321K Sell
11,109
-293
-3% -$8.55K 0.14% 117
2024
Q2
$319K Sell
11,402
-1,466
-11% -$40.4K 0.15% 118
2024
Q1
$357K Buy
12,868
+880
+7% +$24.4K 0.18% 109
2023
Q4
$345K Sell
11,988
-556
-4% -$16.8K 0.19% 108
2023
Q3
$416K Sell
12,544
-1,422
-10% -$50.3K 0.24% 97
2023
Q2
$512K Sell
13,966
-2,210
-14% -$86K 0.28% 93
2023
Q1
$660K Sell
16,176
-2,824
-15% -$122K 0.38% 85
2022
Q4
$974K Sell
19,000
-100
-0.5% -$4.79K 0.5% 65
2022
Q3
$836K Buy
19,100
+5,006
+36% +$243K 0.51% 68
2022
Q2
$739K Hold
14,094
0.38% 79
2022
Q1
$730K Hold
14,094
0.37% 87
2021
Q4
$832K Sell
14,094
-556
-4% -$27.5K 0.38% 84
2021
Q3
$630K Sell
14,650
-80
-0.5% -$3.54K 0.34% 92
2021
Q2
$577K Sell
14,730
-108
-0.7% -$4.2K 0.32% 92
2021
Q1
$538K Buy
14,838
+179
+1% +$6.36K 0.33% 95
2020
Q4
$540K Sell
14,659
-792
-5% -$29.1K 0.35% 90
2020
Q3
$538K Sell
15,451
-2,037
-12% -$71.4K 0.4% 81
2020
Q2
$543K Sell
17,488
-848
-5% -$28.8K 0.44% 78
2020
Q1
$568K Sell
18,336
-2,405
-12% -$81.9K 0.55% 63
2019
Q4
$771K Sell
20,741
-845
-4% -$30.1K 0.62% 60
2019
Q3
$736K Sell
21,586
-1,668
-7% -$60.7K 0.62% 59
2019
Q2
$956K Sell
23,254
-3,342
-13% -$133K 0.84% 35
2019
Q1
$1.07M Sell
26,596
-2,634
-9% -$105K 0.9% 28
2018
Q4
$1.21M Sell
29,230
-1,154
-4% -$47.9K 1.14% 22
2018
Q3
$1.27M Sell
30,384
-845
-3% -$32.5K 1.03% 25
2018
Q2
$1.07M Sell
31,229
-14,482
-32% -$495K 0.92% 27
2018
Q1
$1.54M Sell
45,711
-10,878
-19% -$374K 1.35% 25
2017
Q4
$1.95M Buy
56,589
+1,976
+4% +$67.4K 1.62% 20
2017
Q3
$1.85M Sell
54,613
-64
-0.1% -$2.06K 1.62% 22
2017
Q2
$1.74M Sell
54,677
-1,268
-2% -$40K 1.55% 29
2017
Q1
$1.82M Sell
55,945
-4,610
-8% -$145K 1.61% 27
2016
Q4
$1.87M Sell
60,555
-503
-0.8% -$15.4K 1.68% 25
2016
Q3
$1.96M Sell
61,058
-472
-0.8% -$15.8K 1.84% 20
2016
Q2
$2.06M Sell
61,530
-661
-1% -$21.1K 2.02% 18
2016
Q1
$1.75M Sell
62,191
-460
-0.7% -$13.1K 1.74% 24
2015
Q4
$1.92M Buy
62,651
+927
+2% +$29.2K 1.75% 22
2015
Q3
$1.84M Sell
61,724
-455
-0.7% -$14.6K 2% 15
2015
Q2
$1.98M Buy
62,179
+818
+1% +$26.7K 1.95% 13
2015
Q1
$2.02M Buy
61,361
+594
+1% +$18.9K 1.99% 14
2014
Q4
$1.8M Buy
+60,767
New +$1.74M 1.73% 24

Other funds holding PFE

Leisure Capital Management's PFE Position: Q1 2026 in Review

Leisure Capital Management held its Pfizer (PFE) position steady in Q1 2026 at 9,483 shares worth $266K. The position accounts for 0.09% of the portfolio, ranked #126.

Leisure Capital Management first reported a position in PFE in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.06M in Q2 2016. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Leisure Capital Management held 9,483 shares of Pfizer worth $266K as of Q1 2026.
  • Leisure Capital Management left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.09% of Leisure Capital Management's portfolio in Q1 2026, its #126 holding.
  • Leisure Capital Management first reported a position in Pfizer in Q4 2014 and has held it in 46 quarters since.
  • Leisure Capital Management's Pfizer position peaked at $2.06M in Q2 2016.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Leisure Capital Management's 13F filing for Q1 2026, filed 8 May 2026.